The Burrill Report

The Burrill Report (October 28, 2013): Why You Shouldn't Bank on Wall Street's Drug Forecasts (.MP3,11.88 Mb)

The crystal ball gazers on Wall Street have been coming up short when it comes to forecasting drug sales. In fact, a recent study in Nature Reviews Drug Discovery found more than 60 percent of forecasts were wrong by a margin of more than 40 percent. We spoke to study co-author Myoung Cha, principle with McKinsey & Company, about the study, why there’s little wisdom to garner from crowds, and why investors should remain critical of forecasts and take a dynamic view of such numbers.

October 24, 2013
http://www.burrillreport.com/article-why_you_shouldnt_bank_on_wall_streets_drug_forecasts_.html